Pro-cancer role of CD276 as a novel biomarker for clear cell renal cell carcinoma
CONCLUSION: CD276 expression was significantly increased in ccRCC tissues and cells and positively correlated with patient prognosis. CD276 is a potential prognostic biomarker of ccRCC. Overall, this study provides a potential therapeutic strategy for ccRCC.PMID:38600002 | DOI:10.1016/j.urolonc.2024.03.018
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Zhi-Yu Zhang Jian-Hao Xu Jiang-Lei Zhang Yu-Xin Lin Jun Ou-Yang Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology